Catalyst Wire Dossier Catalyst Wire Dossier

ActiveMatrix

Connective Tissue Allograft
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ActiveMatrix, covering 2022-04-07 to 2026-02-18. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Determine the Safety and Effectiveness of a Connective Tissue Allograft (ActiveMatrix) Verses Standard of Care in Adhesive Capsulitis of the Shoulder [Phase 4]

See pricing